Subventions financées

The blood-brain barrier (BBB) plays an essential role in protecting the brain from blood-borne diseases.

No medications exist that can stop or even slow the progression for Alzheimer Disease (AD).

Two diseases that show very different trajectories have nevertheless led researchers to identify dysfunction in a common brain network.

Each year, over 1,500 Canadians sustain an acute spinal cord injury (SCI), and join close to 40,000 across our nation living with one of the most physically and psychologically devastating of injuries.

Most mental disorders begin in adolescence; however, there are many gaps in our understanding of youth mental health.

Autism spectrum disorders are neurodevelopmental disorders characterized by deficits in social interaction, poor communication, and restricted, stereotyped patterns of behavior.

Recent estimates indicate that 1 in 5 Canadians are affected annually by mood, anxiety and other mental illnesses.

The purpose of this project is to develop promoters. Promoters are pieces of DNA, which act as switches to turn genes on and off.

Dr David Stojdl’s lab has custom‑built an oncolytic virus biotherapy specifically for the treatment of the devastating brain cancer, glioblastoma multiforme (GBM).

Cancer can exhibit relentless growth and relapse because of the enhanced protection of its chromosome ends.